104 related articles for article (PubMed ID: 1988096)
1. Biochemical and genetic characterization of the HBA71 Ewing's sarcoma cell surface antigen.
Fellinger EJ; Garin-Chesa P; Su SL; DeAngelis P; Lane JM; Rettig WJ
Cancer Res; 1991 Jan; 51(1):336-40. PubMed ID: 1988096
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical analysis of Ewing's sarcoma cell surface antigen p30/32MIC2.
Fellinger EJ; Garin-Chesa P; Triche TJ; Huvos AG; Rettig WJ
Am J Pathol; 1991 Aug; 139(2):317-25. PubMed ID: 1867320
[TBL] [Abstract][Full Text] [Related]
3. Comparison of cell surface antigen HBA71 (p30/32MIC2), neuron-specific enolase, and vimentin in the immunohistochemical analysis of Ewing's sarcoma of bone.
Fellinger EJ; Garin-Chesa P; Glasser DB; Huvos AG; Rettig WJ
Am J Surg Pathol; 1992 Aug; 16(8):746-55. PubMed ID: 1497115
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of the pseudoautosomal gene MIC2 in Ewing's sarcoma and peripheral primitive neuroectodermal tumor.
Kovar H; Dworzak M; Strehl S; Schnell E; Ambros IM; Ambros PF; Gadner H
Oncogene; 1990 Jul; 5(7):1067-70. PubMed ID: 1695726
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical profile of monoclonal antibody O13: antibody that recognizes glycoprotein p30/32MIC2 and is useful in diagnosing Ewing's sarcoma and peripheral neuroepithelioma.
Weidner N; Tjoe J
Am J Surg Pathol; 1994 May; 18(5):486-94. PubMed ID: 7513503
[TBL] [Abstract][Full Text] [Related]
6. MIC2 detection in tumors of bone and adjacent soft tissues.
Devaney K; Abbondanzo SL; Shekitka KM; Wolov RB; Sweet DE
Clin Orthop Relat Res; 1995 Jan; (310):176-87. PubMed ID: 7641436
[TBL] [Abstract][Full Text] [Related]
7. EWS rearrangement in Ewing's sarcoma and peripheral neuroectodermal tumor. Molecular detection and correlation with cytogenetic analysis and MIC2 expression.
Ladanyi M; Lewis R; Garin-Chesa P; Rettig WJ; Huvos AG; Healey JH; Jhanwar SC
Diagn Mol Pathol; 1993 Sep; 2(3):141-6. PubMed ID: 8287228
[TBL] [Abstract][Full Text] [Related]
8. MIC2 is a specific marker for Ewing's sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of Ewing's sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberration.
Ambros IM; Ambros PF; Strehl S; Kovar H; Gadner H; Salzer-Kuntschik M
Cancer; 1991 Apr; 67(7):1886-93. PubMed ID: 1848471
[TBL] [Abstract][Full Text] [Related]
9. Immunophenotypic profile and FISH analysis in a case of Ewing's sarcoma.
Papadopoulos N; Tamiolakis D; Lambropoulou M; Alexiadis G; Argyropoulou P; Manavis J; Verettas D; Sivridis E
In Vivo; 2001; 15(4):359-64. PubMed ID: 11695230
[TBL] [Abstract][Full Text] [Related]
10. Generation of human single-chain antibody to the CD99 cell surface determinant specifically recognizing Ewing's sarcoma tumor cells.
Gellini M; Ascione A; Flego M; Mallano A; Dupuis ML; Zamboni S; Terrinoni M; D'Alessio V; Manara MC; Scotlandi K; Picci P; Cianfriglia M
Curr Pharm Biotechnol; 2013; 14(4):449-63. PubMed ID: 22335486
[TBL] [Abstract][Full Text] [Related]
11. MIC2 analysis in pediatric lymphomas and leukemias.
Riopel M; Dickman PS; Link MP; Perlman EJ
Hum Pathol; 1994 Apr; 25(4):396-9. PubMed ID: 8163272
[TBL] [Abstract][Full Text] [Related]
12. Ewing's sarcoma--routine diagnostic utilization of MIC2 analysis: a Pediatric Oncology Group/Children's Cancer Group Intergroup Study.
Perlman EJ; Dickman PS; Askin FB; Grier HE; Miser JS; Link MP
Hum Pathol; 1994 Mar; 25(3):304-7. PubMed ID: 8150461
[TBL] [Abstract][Full Text] [Related]
13. Ewing's tumor X mouse hybrids expressing the MIC2 antigen: analyses using fluorescence CDD-banding and non-isotopic ISH.
Dworzak M; Stock C; Strehl S; Gadner H; Ambros PF
Hum Genet; 1992 Jan; 88(3):273-8. PubMed ID: 1733829
[TBL] [Abstract][Full Text] [Related]
14. Ewing's-sarcoma-associated HBA-71 tumor antigen represents a new differentiation marker of human thymocytes.
Hamilton G; Mallinger R; Havel M
J Cancer Res Clin Oncol; 1989; 115(6):592-6. PubMed ID: 2606935
[TBL] [Abstract][Full Text] [Related]
15. Immunocytochemical study of 12E7 in small round-cell tumours of childhood: an assessment of its sensitivity and specificity.
Ramani P; Rampling D; Link M
Histopathology; 1993 Dec; 23(6):557-61. PubMed ID: 8314240
[TBL] [Abstract][Full Text] [Related]
16. Neuroectoderm-associated antigens on Ewing's sarcoma cell lines.
Lipinski M; Braham K; Philip I; Wiels J; Philip T; Goridis C; Lenoir GM; Tursz T
Cancer Res; 1987 Jan; 47(1):183-7. PubMed ID: 3024814
[TBL] [Abstract][Full Text] [Related]
17. Specificity and function of monoclonal antibodies directed against Ewing sarcoma cells.
Shi LR; Eichelbauer D; Borchard F; Jürgens H; Göbel U; Schneider EM
Cancer Immunol Immunother; 1994 Mar; 38(3):208-13. PubMed ID: 8124690
[TBL] [Abstract][Full Text] [Related]
18. Cell surface membrane antigen present on neuroblastoma cells but not fetal neuroblasts recognized by a monoclonal antibody (KP-NAC8).
Matsumura T; Sugimoto T; Sawada T; Amagai T; Negoro S; Kemshead JT
Cancer Res; 1987 Jun; 47(11):2924-30. PubMed ID: 3567910
[TBL] [Abstract][Full Text] [Related]
19. A panel of monoclonal antibodies which discriminate neuroblastoma from Ewing's sarcoma, rhabdomyosarcoma, neuroepithelioma, and hematopoietic malignancies.
Donner L; Triche TJ; Israel MA; Seeger RC; Reynolds CP
Prog Clin Biol Res; 1985; 175():347-66. PubMed ID: 3991736
[No Abstract] [Full Text] [Related]
20. Phenotypic characterization of Ewing sarcoma cell lines with monoclonal antibodies.
Lipinski M; Braham K; Philip I; Wiels J; Philip T; Dellagi K; Goridis C; Lenoir GM; Tursz T
J Cell Biochem; 1986; 31(4):289-96. PubMed ID: 3760036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
